Neurologic complications of paget disease of bone

Endocrine Practice

Volumn 15, Issue 2, 2009, Pages 158-166

  Rubin, Daniel J ^a   Levin, Robert M ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; ETIDRONIC ACID; PAMIDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

ALKALINE PHOSPHATASE BLOOD LEVEL; BONE RADIOGRAPHY; BONE SCINTISCANNING; BRAIN HEMORRHAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE PARALYSIS; DEMENTIA; FACE PAIN; FACIAL NERVE PARALYSIS; FUNCTIONAL ASSESSMENT; HEADACHE; HEARING LOSS; HUMAN; HYDROCEPHALUS; MYELITIS; NERVE COMPRESSION; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PAGET BONE DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PREVALENCE; REVIEW; SARCOMA; SPINAL CORD DISEASE; BIOLOGICAL MODEL; MEDLINE; NEUROLOGIC DISEASE; PATHOLOGY;

HUMANS; MEDLINE; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; OSTEITIS DEFORMANS;

EID: 67549085395     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.15.2.158     Document Type: Review

References (78)

1. Hadjipavlou AG, Gaitanis IN, Kontakis GM. Paget's disease of the bone and its management. J Bone Joint Surg Br. 2002;84:160-169.
2. Ralston SH, Langston AL, Reid IR. Pathogenesis and management of Paget's disease of bone. Lancet. 2008;372: 155-163.
3. Gennari L, Merlotti D, Martini G, Nuti R. Paget's disease of bone in Italy. J Bone Miner Res. 2006;21(suppl 2):P14-P21.
4. Cooper C, Harvey NC, Dennison EM, van Staa TP. Update on the epidemiology of Paget's disease of bone. J Bone Miner Res. 2006;21(suppl 2):P3-P8.
5. Chen JR, Rhee RS, Wallach S, Avramides A, Flores A. Neurologic disturbances in Paget disease of bone: response to calcitonin. Neurology. 1979;29:448-457.
6. Clarke CR, Harrison MJ. Neurological manifestations of Paget's disease. J Neurol Sci. 1978;38:171-178.
7. Moiyadi AV, Praharaj SS, Pillai VS, Chandramouli BA. Hydrocephalus in Paget's disease [with discussion]. Acta Neurochir (Wien). 2006;148:1297-1300.
8. Friedman P, Sklaver N, Klawans HL Jr. Neurologic manifestations of Paget's disease of the skull. Dis Nerv Syst. 1971;32:809-817.
9. Young CA, FraserWD,Mackenzie IJ. Detection of hearing impairment and handicap in Paget's disease of bone using a simple scoring system: a case control study. Bone. 2007;40:189-193.
10. Martínez-Lage JF, Saez V, Requena L, Martínez-Barba E, Poza M. Cranial epidural hematoma in Paget's disease of the bone. Intensive Care Med. 2000;26:1582-1583.
11. Kovach MJ, Waggoner B, Leal SM, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab. 2001;74:458-475.
12. Buckawalter JA, Mickelson MR, Emerson RL. Ulnar nerve palsy in Paget's disease. Clin Orthop Relat Res. 1977;127:212-213.
13. Direkze M, Milnes JN. Spinal-cord compression in Paget's disease. Br J Surg. 1970;57:239-240.
14. Feldman RG, Culebras A, Schmidek HH. Paget's disease and the nervous system. J Am Geriatr Soc. 1979;27:1-8.
15. Bone HG. Nonmalignant complications of Paget's disease. J Bone Miner Res. 2006;21(suppl 2):P64-P68.
16. Eulry F, Poirier JM, Perard D, Bergamasco P, Lechevalier D, Magnin J. Cauda equina syndrome with pagetic vertebral fusion: clinical recovery under calciumvitamin D supplementation plus clodronate after apparent failure of pamidronate and acquired resistance to etidronate. Rev Rhum Engl Ed. 1997;64:495-499.
17. Douglas DL, Duckworth T, Kanis JA, Jefferson AA, Martin TJ, Russell RG. Spinal cord dysfunction in Paget's disease of bone: has medical treatment a vascular basis? J Bone Joint Surg Br. 1981;63B:495-503.
18. Poncelet A. The neurologic complications of Paget's disease. J Bone Miner Res. 1999;14(suppl 2):88-91.
19. Schmidek HH. Neurologic and neurosurgical sequelae of Paget's disease of bone. Clin Orthop Relat Res. 1977;127: 70-77.
20. Cartlidge NE, McCollum JP, Ayyar RD. Spinal cord compression in Paget's disease. J Neurol Neurosurg Psychiatry. 1972;35:825-828.
21. Hadjipavlou AG, Katonis PG, Tzermiadianos MN, Tsoukas GM, Sapkas G. Principles of management of osteometabolic disorders affecting the aging spine. Eur Spine J. 2003;12(suppl 2):S113-S131.
22. Sadar ES, Walton RJ, Gossman HH. Neurological dysfunction in Paget's disease of the vertebral column. J Neurosurg. 1972;37:661-665.
23. Siris ES, Lyles KW, Singer FR, Meunier PJ. Medical management of Paget's disease of bone: indications for treatment and review of current therapies. J Bone Miner Res. 2006;21(suppl 2):P94-P98.
24. Selby PL. Guidelines for the diagnosis and management of Paget's disease: a UK perspective. J Bone Miner Res. 2006;21(suppl 2):P92-P93.
25. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res. 2002;17:465-471.
26. Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ III. Morbidity and mortality associated with Paget's disease of bone: a population-based study. J Bone Miner Res. 2008;23:819-825.
27. Eekhoff ME, van der Klift M, Kroon HM, et al. Paget's disease of bone in the Netherlands: a population-based radiological and biochemical survey the Rotterdam Study. J Bone Miner Res. 2004;19:566-570.
28. Kanis JA, ed. Pathophysiology and Treatment of Paget's Disease of Bone. 2nd ed. London, UK: Matin Dunitz Ltd, 1998.
29. Eastell R. Biochemical markers of bone turnover in Paget's disease of bone. Bone. 1999;24(5 suppl):49S-50S.
30. Lander P, Hadjipavlou A. Intradiscal invasion of Paget's disease of the spine. Spine. 1991;16:46-51.
31. Shannon FT, Hopkins JS. Paget's sarcoma of the vertebral column with neurological complications. Acta Orthop Scand. 1977;48:385-390.
32. Eretto P, Krohel GB, Shihab ZM, Wallach S, Hay P. Optic neuropathy in Paget's disease. Am J Ophthalmol. 1984;97:505-510.
33. Hadjipavlou A, Lander P. Paget disease of the spine. J Bone Joint Surg Am. 1991;73:1376-1381.
34. Briesacher BA, Orwig D, Seton M, Omar M, Kahler KH. Medical care costs of Paget's disease of bone in a privately insured population. Bone. 2006;38:731-737.
35. Rosenkrantz JA, Wolf J, Kaicher JJ. Paget's disease (osteitis deformans): review of one hundred eleven cases. AMA Arch Intern Med. 1952;90:610-633.
36. Hartman JT, Dohn DF. Paget's disease of the spine with cord or nerve-root compression. J Bone Joint Surg Am. 1966;48:1079-1084.
37. Meunier PJ, Salson C, Mathieu L, et al. Skeletal distribution and biochemical parameters of Paget's disease. Clin Orthop Relat Res. 1987;217:37-44.
38. Hens L, van den Bergh R. Hydrocephalus-dementia-complex in Paget's disease. Clin Neurol Neurosurg. 1979;81: 255-263.
39. Ikeda K, Kinoshita M, Aoki K, Tomatsuri A. Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy. Mov Disord. 1997;12:241-242.
40. Roohi F, Mann D, Kula RW. Surgical management of hydrocephalic dementia in Paget's disease of bone: the 6-year outcome of ventriculo-peritoneal shunting. Clin Neurol Neurosurg. 2005;107:325-328.
41. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377-381.
42. Kimonis VE, Mehta SG, Fulchiero EC, et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A. 2008;146A:745-757.
43. Boutin RD, Spitz DJ, Newman JS, Lenchik L, Steinbach LS. Complications in Paget disease at MR imaging. Radiology. 1998;209:641-651.
44. Mancebo-Aragoneses L, Lacambra-Calvet C, Jorge-Blanco A, Coarasa-Cerdan A, Guadaño-Salvadores V. Paget's disease of the skull with osteosarcoma and neurological symptoms associated. Eur Radiol. 1998;8:1145-1147.
45. Huvos AG, Sundaresan N, Bretsky SS, Butler A. Osteogenic sarcoma of the skull: a clinicopathologic study of 19 patients. Cancer. 1985;56:1214-1221.
46. Young HA, Hardy DG, Ashleigh R. Osteogenic sarcoma of the skull complicating Paget's disease: case report. Neurosurgery. 1983;12:454-457.
47. Deyrup AT, Montag AG, Inwards CY, Xu Z, Swee RG, Unni KK. Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases. Arch Pathol Lab Med. 2007;131:942-946.
48. Ramesh VG, Deiveegan K, Soundappan V. Vertex extradural hematoma in association with Paget's disease ofthe skull. Neurol India. 2005;53:115-116.
49. Monsell EM. The mechanism of hearing loss in Paget's disease of bone. Laryngoscope. 2004;114:598-606.
50. Khetarpal U, Nadol JB Jr, Glynn RJ. Idiopathic sudden sensorineural hearing loss and postnatal viral labyrinthitis: a statistical comparison of temporal bone findings. Ann Otol Rhinol Laryngol. 1990;99:969-976.
51. Wolf P. Creativity and chronic disease: Ludwig vanBeethoven (1770-1827). West J Med. 2001;175:298.
52. Chakravorty NK. Neurological complications of Paget's disease of bone. Br J Clin Pract. 1985;39:335-338.
53. Altman RD, Brown M, Gargano F. Low back pain in Paget's disease of bone. Clin Orthop Relat Res. 1987;217: 152-161.
54. Oikonomou A, Birbilis T, Gymnopoulou E, Prassopoulos P. Paget disease of the spine manifested by thoracic and lumbar epidural lipomatosis: magnetic resonance imaging findings. Spine. 2007;32:E789-E792.
55. Relea A, García-Urbón MV, Arboleya L, Zamora T. Extramedullary hematopoiesis related to Paget's disease. Eur Radiol. 1999;9:205-207.
56. Huang TL, Cohen NJ, Sahgal S, Tseng CH. Osteosarcoma complicating Paget's disease of the spine with neurologic complications. Clin Orthop Relat Res. 1979;141:260-265.
57. Tessitore E, Luzi M, Lobrinus JA, Samaras N, Trombetti A. Cervical Paget disease of bone with spinal cord compression due to atlanto-axial instability: a case report and review of the literature. Spine. 2008;33:E85-E89.
58. Schumacher M, Levy A, Beck U, Remagen W. Paget's disease with spinal cord compression: favourable course after decompression and calcitonin treatment in two cases. Eur Neurol. 1977;15:116-120.
59. Gruszkiewicz J, Doron Y, Borovich B, Zaaroor M. Spinal cord compression in Paget's disease of bone with reference to sarcomatous degeneration and calcitonin treatment. Surg Neurol. 1987;27:117-125.
60. Jawad AS, Berry H. Spinal cord compression in Paget's disease of bone treated medically. J R Soc Med. 1987;80: 319-321.
61. Siegelman SS, Levine SA,Walpin L. Paget's disease with spinal cord compression. Clin Radiol. 1968;19:421-425.
62. Wallace E, Wong J, Reid IR. Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. Arch Intern Med. 1995;155:1813-1815.
63. Davis DP, Bruffey JD, Rosen P. Coccygeal fracture and Paget's disease presenting as acute cauda equina syndrome. J Emerg Med. 1999;17:251-254.
64. Richter RL, Semble EL, Turner RA, Challa VR. An unusual manifestation of Paget's disease of bone: spinal epidural hematoma presenting as acute cauda equina syndrome. J Rheumatol. 1990;17:975-978.
65. Herzberg L, Bayliss E. Spinal-cord syndrome due to noncompressive Paget's disease of bone: a spinal-artery steal phenomenon reversible with calcitonin. Lancet. 1980;2:13-15.
66. Wootton R, Reeve J, Veall N. The clinical measurement of skeletal blood flow. Clin Sci Mol Med. 1976;50:261-268.
67. Walton KR, Green JR, Reeve J, Wootton R. Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy. Bone. 1985;6:29-31.
68. Wootton R, Reeve J, Spellacy E, Tellez-Yudilevich M. Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy. Clin Sci Mol Med. 1978;54: 69-74.
69. Jattiot F, Goupille P, Azais I, et al. Fourteen cases of sarcomatous degeneration in Paget's disease. J Rheumatol. 1999;26:150-155.
70. Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone. J Bone Miner Res. 2006;21(suppl 2):P58-P63.
71. Russell RG, Xia Z, Dunford JE, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci. 2007;1117:209-257.
72. Hosking D, Lyles K, Brown JP, et al. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate [published correction appears in J Bone Miner Res. 2007;22:773]. J Bone Miner Res. 2007;22:142-148.
73. Isasi C, Sanz J, Hijós M, Vaquero M, Saucedo G, Andreu JL. Successful treatment of optic neuropathy in osteitis deformans. Rheumatology (Oxford). 2002;41:948-950.
74. Fu KK, Ko A. The treatment with alendronate in hemifacial spasm associated with Paget's disease of bone. Clin Neurol Neurosurg. 2000;102:48-51.
75. Pane A. Paget disease manifesting with compressive sixthnerve palsy that resolved with intravenous zoledronic acid therapy. Arch Ophthalmol. 2007;125:1440-1441.
76. Morton A. Pagetic hydrocephalus treated with zoledronate. Ann Rheum Dis. 2005;64:1386.
77. Chung G, Keen RW. Zoledronate treatment in active Paget's disease. Ann Rheum Dis. 2003;62:275-276.
78. Fernández JM, Mederer S, Alvarez-Sabín J, Segura A, Codina A. Hemifacial spasm associated with Paget's disease of bone: good response to calcitonin. Neurology. 1991;41:1322-1323.